中文 | English
Return
Total: 370 , 1/37
Show Home Prev Next End page: GO
Author:( Nan DU)

1.Novel molecular diagnostic markers for liver fibrosis

Jinghua DU ; Yuemin NAN

Journal of Clinical Hepatology 2017;33(3):445-450

2.Study on the Retrovirus Mediated Transfer of GM-CSF cDNA in Hematopoietic Progenitor Cells

Nan DU ; Qinyu WANG ; Xin LIU

Chinese Journal of Cancer Biotherapy 1995;0(02):-

3.Clinical trial of biochemotherapy versus chemotherapy or biotherapy for malignant melanoma

Nan DU ; Liushu LI ; Wenhua XIAO

Medical Journal of Chinese People's Liberation Army 1982;0(03):-

4.Studies on the expression of hematopoietic growth factor modulated by Egr-1 promoter sequence in transcriptional targeting by chemotherapeutic agents

Nan DU ; Xuetao PEI ; Jinming ZHOU

Medical Journal of Chinese People's Liberation Army 2001;0(12):-

5.Feasibility of promoting blood circulation by removing blood stasis in target interfering ADUB endometrial hyperplasia

Fengjie HE ; Nan LI ; Xinjie DU

China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(05):-

6.STUDIES ON THE EXPRESSION OF GM-CSF REGULATED BY RADIO INDUCIBLE PROMOTER

Nan DU ; Xuetao PEI ; Chengj LUO

Medical Journal of Chinese People's Liberation Army 1983;0(05):-

7.Effects of Artesunate on hepatic fibrosis and its mechanism.

Yan DU ; Li-nan LI ; Bu-wu FANG

Chinese Journal of Applied Physiology 2015;31(1):14-17

9.Clinical study of the treatment of advanced non small cell lung cancer in elderly over 70 years by gemcitabine

Liushu LI ; Ruliang WANG ; Hui ZHAO ; Jianhua ZHU ; Nan DU

Chinese Journal of Geriatrics 2001;0(01):-

10.Preliminary analysis of clinical images of SARS

Xiangke DU ; Wanjiang YU ; Silun WANG ; Qizhi ZHU ; Nan HONG

Chinese Journal of Radiology 2001;0(09):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 370 , 1/37 Show Home Prev Next End page: GO